GG2 intermediate risk prostate cancer - population-based analysis of AS outcomes confirms worse cancer-specific and overall-survival compared to active treatment
Publication/Presentation Date
7-2020
Volume
19
Issue
2
First Page
1912
Last Page
1913
Published In/Presented At
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
Department(s)
Administration and Leadership
Document Type
Article
COinS